1. Home
  2. AWX vs LYRA Comparison

AWX vs LYRA Comparison

Compare AWX & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWX
  • LYRA
  • Stock Information
  • Founded
  • AWX 1998
  • LYRA 2005
  • Country
  • AWX United States
  • LYRA United States
  • Employees
  • AWX N/A
  • LYRA 30
  • Industry
  • AWX Environmental Services
  • LYRA Medical/Dental Instruments
  • Sector
  • AWX Utilities
  • LYRA Health Care
  • Exchange
  • AWX Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • AWX 9.7M
  • LYRA 11.3M
  • IPO Year
  • AWX 1998
  • LYRA 2020
  • Fundamental
  • Price
  • AWX $2.46
  • LYRA $6.85
  • Analyst Decision
  • AWX
  • LYRA Hold
  • Analyst Count
  • AWX 0
  • LYRA 1
  • Target Price
  • AWX N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • AWX 3.8K
  • LYRA 14.2K
  • Earning Date
  • AWX 08-08-2025
  • LYRA 08-12-2025
  • Dividend Yield
  • AWX N/A
  • LYRA N/A
  • EPS Growth
  • AWX 306.94
  • LYRA N/A
  • EPS
  • AWX 0.03
  • LYRA N/A
  • Revenue
  • AWX $78,200,000.00
  • LYRA $770,000.00
  • Revenue This Year
  • AWX N/A
  • LYRA N/A
  • Revenue Next Year
  • AWX N/A
  • LYRA $123.46
  • P/E Ratio
  • AWX $81.28
  • LYRA N/A
  • Revenue Growth
  • AWX N/A
  • LYRA N/A
  • 52 Week Low
  • AWX $2.10
  • LYRA $3.81
  • 52 Week High
  • AWX $3.99
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • AWX 44.15
  • LYRA 42.34
  • Support Level
  • AWX $2.48
  • LYRA $6.91
  • Resistance Level
  • AWX $2.60
  • LYRA $7.50
  • Average True Range (ATR)
  • AWX 0.03
  • LYRA 0.33
  • MACD
  • AWX -0.00
  • LYRA 0.06
  • Stochastic Oscillator
  • AWX 22.22
  • LYRA 16.18

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: